SIKH LEADERSHIP SUMMIT 2016
Friday, November 18, 2016, 6:00pm-9:00pm
The Paley Center For Media, 25 West 52nd Street, New York, NY 10019
Dr. Amar Sawhney
President and CEO, Ocular Therapeutix, Inc.
Amarpreet Sawhney is the President and CEO of Ocular Therapeutix, Inc. (NASDAQ: OCUL) and Chairman of Augmenix, Inc. Ocular Therapeutix is focused on solving unmet needs in ophthalmic drug delivery. Augmenix is focused on absorbable materials that can help improve outcomes and targeting of radiotherapy. Prior to this he was Founder and CEO of Confluent Surgical, a biosurgery company, based in Waltham, MA. Confluent was acquired by Covidien. Before Confluent, Dr. Sawhney was the technology founder of Focal, Inc. (acquired by Genzyme) and of Access Closure, Inc. (acquired by Cardinal Health). Dr. Sawhney’s innovations are the subject of over 120 issued and pending patents in biomaterials and bio-surgery. His inventions include several “first of a kind” surgical sealants to be approved by the United States FDA including DuraSeal for neurosurgery, FocalSeal for Lung surgery, and Mynx for femoral puncture sealing.
In addition to being an entrepreneur Amar, has also created a platform to support other entrepreneurs. He and his partner, Fred Khosravi, have founded Incept LLC, whose vision is to serve as an “enabler” of healthcare entrepreneurs. Incept counts among its companies, Embolic Protection, Endo-Tex, and Sadra Medical (all acquired by Boston Scientific), Access Closure, Inc. Hotspur, Inc (acquired by Teleflex), Ostial LLC, and The Stroke Project (TSP) in California, Axtria and MarketRx in New Jersey (acquired by Cognizant), Maya Medical (acquired by Covidien), Augmenix, and Ocular Therapeutix, in Massachusetts, and Neurolutions in St. Louis. Amar currently serves on the board of directors of EcoSikh, Axtria, The Stroke Project, Augmenix and Ocular Therapeutix, he is also a Founder of the latter two companies. Through his family Foundation, Dr. Sawhney has been active in charitable causes that are dear to him, which include education as well as wildlife and the environment, with a focus on India.
Dr. Sawhney has been recognized by several awards including being named the Dr. Sawhney has been recognized by several awards including being named the “Champion of Change” by the WhiteHouse and “Outstanding American by Choice” by the US Citizenship and Immigration Service, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, The Immigrant Entrepreneur Award, Indian Institute of Delhi Distinguished Alumni Award, and the University of Texas Outstanding Young Engineering Graduate award. He was recognized by India New England News as one of the 50 most influential people of Indian origin in New England and was recently awarded the New England Choice Award for Entrepreneurship. Dr. Sawhney’s companies and inventions have touched over 5 million patients and have created over 2000 jobs to date.
Dr. Sawhney holds an M.S. and a Ph.D. in Chemical Engineering from the University of Texas at Austin and a B. Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi. He is married to Deepika Sawhney. They have a son Anhad (13) and a daughter Pria (11), and live in Lexington, Massachusetts.